Loading…
P391 The availability of anti-TNF agents is associated with reduced early surgical requirements in Crohn’s disease but not in ulcerative colitis. A nationwide study from the Eneida registry
Abstract Background It has been suggested that biological therapies might change the natural history of IBD, avoiding surgery in a proportion of patients. Retrospective series show controversial results and include small samples sizes. Methods To assess the impact of the availability of anti-TNF age...
Saved in:
Published in: | Journal of Crohn's and colitis 2018-01, Vol.12 (supplement_1), p.S301-S302 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Abstract
Background
It has been suggested that biological therapies might change the natural history of IBD, avoiding surgery in a proportion of patients. Retrospective series show controversial results and include small samples sizes.
Methods
To assess the impact of the availability of anti-TNF agents on the need for early surgery (within the first 5 years from IBD diagnosis) in both CD and UC, all those incident patients who were diagnosed in two different periods (before and after anti-TNF availability) were identified from the ENEIDA Registry (a large, prospectively maintained database of the Spanish Working Group in IBD –GETECCU-). Incident cohorts included the time periods 1990–1995 and 2007–2012 for CD, and 1995–2000 and 2007–2012 for UC. Patients lacking dates of IBD diagnosis or surgery, as well as those with a follow-up |
---|---|
ISSN: | 1873-9946 1876-4479 |
DOI: | 10.1093/ecco-jcc/jjx180.518 |